Google Alert - cannabidiol for epilepsy

	cannabidiol for epilepsy Daily update ⋅ December 8, 2019
	NEWS
	Cannabidiol Cuts Seizures in Another Rare Epilepsy MedPage Today BALTIMORE -- Adjunctive cannabidiol, or CBD, (Epidiolex) met its primary endpoint of reducing seizures in patients with tuberous sclerosis complex ... Flag as irrelevant
	GW Pharma Shares Clinical Trial Data to Support Epidiolex Safety and Efficacy New Cannabis Ventures Epilepsy is the most common neurological feature of TSC,1,2,3 a rare and severe childhood-onset disease, .... GW's lead product, EPIDIOLEX® (cannabidiol) oral solution is commercialized in the US by its U.S. subsidiary Greenwich ... Flag as irrelevant
	GW Pharmaceuticals plc (GWPH) Reaches $101.05 After 7.00% Down Move; Zogenix, Inc. (ZGNX ... The Broch Herald Some Historical GWPH News: 24/05/2018 – Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Cannabidiol Isolate to Sundial; ... FDA panel unanimously votes for GW Pharma's cannabis-derived epilepsy drug; ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback